ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 38530 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 38530; 2) Community: the network communities that were significantly associated with the response to NSC 38530; 3) Molecule: the relationships between components within communities and NSC 38530; 4) MDR: the compounds that were significantly associated with the NSC 38530.

NSC Compound Enrichment Correlation
NSC 708049 Piperazine-2,2,5,5-tetracarbonitrile, 3,6-dipropyl- 0.0375780807984386 0.67866305
NSC 711733 Null 0.0375780807984386 0.46370589
NSC 724628 4,11-bis[[2-(dimethylamino)ethyl]-amino]-1H-naphtho[2,3-f]in dole-5,10-dione 0.0375780807984386 0.071535858
NSC 727049 11-(6'-Aminohexylidene]-5,6-dihydro-5-keto-2,3-dimethoxy-6-m ethyl-8,9-methylenedioxy-11H-indeno[1,2-c]isoquinoline 0.0375780807984386 0.20295807
NSC 758662 Lovastatin [USAN] 0.0375780807984386 -0.18227866
NSC 113943 6-Bromosangivamycin 0.0375780807984392 0.42616342
NSC 135077 BERSALDEGENIN 1,3,5-ORTHOACETATE 0.0375780807984392 0.26370403
NSC 337851 Pregna-1,4-diene-3,11,20-trione, 21-[[[[3,6-bis(dimethylamino)-9-acridinyl]thio]acetyl]oxy]-17-hydroxy- 0.0375780807984392 0.32166606
NSC 349174 Oxanthrazole 0.0375780807984392 -0.16012948
NSC 382006 Null 0.0375780807984392 0.82796745
Total:84  Current:71    [First] [Prev] [Next] [Last]